Call for notes!


Are you a medical student, basic physician trainee or Immunology/Immunopathology advanced trainee who is studying Immunology?

We are looking to boost the content of the notesonimmunology website.

If you have made original study notes that you think could be of benefit to others we would love to add you as a contributor.

Please send the notes in MS Word or Powerpoint to ssas7805@med.usyd.edu.au . Be sure to acknowledge the original source of any figures and tables and to include your name on your work.

notesonimmunology is a free, online, collaborative resource that is not for profit. There is no renumeration for contributions, however you will be listed as a contributor on the website.


notesonimmunology : 2017 wrap-up

Screen Shot 2017-12-18 at 8.21.48 pm

2017 was our busiest year here at notesonimmunology with over 2100 views from all over the world.

Our top 5 countries represented were:

  1. Australia
  2. USA
  3. India
  4. Saudi Arabia
  5. Egypt

The most accessed pages this year were:

  1. MCQ
  2. RCPA Part I Written Exam
  3. Tips on passing the RACP exam
  4. Nephelometry and IgG subclasses
  5. IPEX syndrome


Our biggest upload in 2017 was in relation to the RCPA Part I Written and Part II Viva exams.

Thank you for being a part of notesonimmunology in 2017. Wishing you a safe and happy holiday season and looking forward to more immunological banter in 2018.





An 8yr old girl suffers life threatening anaphylaxis after eating peanut butter for the second time. Of the following which is NOT part of a safe medical management plan?

a) Measurement of convalescent serum tryptase level

b) Measurement of peanut specific IgE

c) Strict peanut avoidance

d) Prescription of an adrenaline auto-injector

e) Subcutaneous immunotherapy to peanut

Click here for answer


Happy New Year!

Screen Shot 2015-12-30 at 1.30.44 pm

notesonimmunology has continued to grow over the last two years and had around 1700 views in 2015!

Click here for the full report

Many thanks to those students, physician trainees and Immunology advanced trainees who are visiting the site.

The weekly MCQ will continue through 2016.

I would love to hear your feedback on the site and any additional resources that you would find useful.

All the best for a safe and happy New Year.




A patient is newly diagnosed with HIV infection. CD4+ T-cell count is 700 cells/microL (RR 500-1200) and HIV viral load is >1000000 copies/mL. In regard to management which statement is CORRECT?

a) There are benefits to commencing Anti-retroviral therapy (ART) when CD4+ T-cell count is >500 cells/mL.

b) If the virus is CCR5-tropic then Maraviroc should be prescribed

c) The patient should be advised to take ART on alternate months i.e. 1 month on therapy and 1 month off

d) The patient should be commenced on PJP prophylaxis

e) The patient is an elite controller

Click here for Answer